Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules

Human Immunology

Volumn 60, Issue 3, 1999, Pages 177-186

  Tomiyama, Hiroko ^a   Sakaguchi, Takashi ^b   Miwa, Kiyoshi ^d   Oka, Shinichi ^c   Iwamoto, Aikichi ^b   Kaneko, Yutaro ^d   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d Kawasaki 220   (Japan)

Author keywords

CTL clone; CTL epitope; HIV 1; HLA B*5101

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B35 ANTIGEN; HLA B8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELISM; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; ASIAN CONTINENTAL ANCESTRY GROUP; CLONE CELLS; EPITOPES; HIV SEROPOSITIVITY; HIV-1; HLA-B ANTIGENS; HUMANS; OLIGOPEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032929273     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00113-X     Document Type: Article

References (41)

1. Langlade-Demoyen P., Ngo-Giang-Huong N., Ferchal F., Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest. 93:1994;1293.
2. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T., Takiguchi M., Schultz T., McMichael A., Whittle H. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:1995;59.
3. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., Martin M.A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol. 72:1998;164.
4. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type I syndrome. J Virol. 68:1994;4650.
5. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature. 370:1994;463.
6. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B.A., Shaw G.M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3:1997;205.
7. Goulder P.J.R., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., Giangrande P., Luzzi G., Morgan B., Edwards A., McMichael A.J., Rowland-Jones S. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3:1997;212.
8. Westby M., Manca F., Dalgleish A.G. The role of host immune responses in determining the outcome of HIV infection. Immunol Today. 17:1996;120.
9. Kaslow R.A., Carrington M., Apple R., Park L., Muñoz A., Saah A.J., Goedert J.J., Winkler C., O'Brien S.J., Rinaldo C., Detels R., Blattner W., Phair J., Erlich H., Mann D.L. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med. 2:1996;405.
10. Smeraldi R.S., Fabio G., Lazzarin A., Eisera N.B., Moroni M., Zanussi C. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet. 22:1986;1187.
11. Smeraldi R.S., Fabio G., Lazzarin A., Eisera N., Uberti Foppa C., Moroni M., Zanussi C. HLA-associated susceptivility to AIDS HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts . Hum Immunol. 22:1988;73.
12. Just J.J. Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome. Hum Immunol. 44:1995;156.
13. Tokunaga K., Ishikawa Y., Ogawa A., Wang H., Mitsunaga S., Moriyama S., Lin L., Bannai M., Watanabe Y., Kashiwase K., Tanaka H., Akaza T., Tadokoro K., Juji T. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics. 46:1997;199.
14. Falk K., Rötzshke O., Takiguchi M., Gnau V., Stevanovíc S., Jung G., Rammensee H.G. Peptide motifs of HLA-B51, -B52, and -B78 molecules, and implications for Behçet's disease. Int Immunol. 7:1995;223.
15. Kikuchi A., Sakaguchi T., Miwa K., Takamiya Y., Rammensee H.G., Kaneko Y., Takiguchi M. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics. 43:1996;268.
16. Sakaguchi T., Ibe M., Miwa K., Kaneko Y., Yokota S., Tanaka K., Takiguchi M. Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules, HLA-B*5101. Immunogenetics. 45:1997;259.
17. Falk K., Rötzschke O., Grahovac B., Schendel D., Stenovíc S., Jung G., Rammensee H.G. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics. 38:1993;161.
18. Schönbach C., Ibe M., Shiga H., Takamiya Y., Miwa K., Nokihara K., Takiguchi M. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. J Immunol. 154:1995;5951.
19. Hill A.V.S., Elvin J., Willis A.C., Aidoo M., Allsopp C.E.M., Gotch F.M., Gao X.M., Takiguchi M., Greenwood B.M., Townsend A.R.M., McMichael A.J., Whittle H.C. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360:1992;434.
20. Hayashi H., Ennis P.D., Ariga H., Salter R.D., Parham P., Kano K., Takiguchi M. HLA-B51 and HLA-Bw52 differ only by two amino acids which are in the helical region of α1 domain. J Immunol. 142:1989;306.
21. Matsumoto K., Yamamoto J., Hiraiwa M., Kano K., Takiguchi M. Discrimination of HLA- B5 cross reactive group antigen by human allospecific CTL clones. Transplantation. 49:1990;1164.
22. Shioda T., Shibuta H. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology. 175:1990;139.
23. Shiga H., Shioda T., Tomiyama H., Takamiya Y., Oka S., Kimura S., Yamaguchi Y., Gojoubori T., Rammensee H.G., Miwa K., Takiguchi M. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS. 10:1996;1075.
24. Tomiyama H., Miwa K., Shiga H., Ikeda-Moore Y., Oka S., Iwamoto A., Kaneko Y., Takiguchi M. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. J Immunol. 158:1997;5026.
25. Ikeda-Moore Y., Tomiyama H., Miwa K., Oka S., Iwamoto A., Kaneko Y., Takiguchi M. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes strong epitopes are derived from V regions of HIV-1 . J Immunol. 159:1997;6242.
26. Sipsas N.V., Kalams S.A., Trocha A., He S., Blattner W.A., Walker B.D., Johnson R.P. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J Clin Invest. 99:1997;752.
27. Aido M., Lalani A., Allsopp C.E.M., Plebanski M., Meisner S.J., Krausa P., Browning M., Morris-Jones S., Gotch F., Fidock D.A., Takiguchi M., Robson K.J.H., Greenwood B.M., Druilhe P., Whitte H.C., Hill A.V.S. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet. 345:1995;1003.
28. Nixon D.F., Townsend A.R.M., Elvin J.G., Rizza C.R., Gallwey J., McMichael A.J. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature. 336:1988;484.
29. Goulder P.J.R., Edwards A., Phillips R.E., McMichael A.J. Identification of a novel HLA- B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef. AIDS. 11:1997;536.
30. Goulder P.J.R., Bunce M., Krausa P., Mcintyre K., Crowley S., Morgan B., Edwards A., Giangrande P., Phillips R.E., McMichael A.J. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retr. 12:1996;1691.
31. Goulder P.J., Edwards A., Phillips R.E., McMichael A.J. Identification of a novel HLA- B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides. AIDS. 11:1997;930.
32. + T cells in the central region of the HIV-1 nef protein. J Immunol. 146:1991;1560.
33. Phillips R.E., Rowland-Jones S., Nixon D.F., Gotch F.M., Edwards J.P., Ogunlesi A.O., Elvin J.G., Rothbard J.A., Bangham C.R.M., Rizza C.R., McMichael A.J. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354:1991;453.
34. McAdam S., Klenerman P., Tussey L., Rowland-Jones S., Lalloo D., Phillips R., Edwards A., Giangrande P., Brown A.L., Gotch F., McMichael A.J. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol. 155:1995;2729.
35. Meier U.C., Klenerman P., Griffin P., James W., Köppe B., Larder B., McMichael A.J., Phillips R. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science. 270:1995;1360.
36. Dibrino M., Parker K.C., Shiloach J., Turner R.V., Tsuchida T., Garfield M., Biddison W.E., Coligan J.E. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. J Immunol. 152:1994;620.
37. Meier U.C., Klenerman P., Griffin P., James W., Köppe B., Larder B., McMichael A.J., Philliphs R. Cytotoxic T lymphocyte lysis inhibited by variable HIV-1 mutants. Science. 270:1995;1360.
38. Johnson R.P., Trocha A., Buchanan T.M., Walker B.D. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in conserved region of the human immunodeficiency virus type I envelope glycoprotein definition of minimum epitopes and analysis of the effects of sequence variation . J Exp Med. 175:1992;961.
39. Culmann-Penciolelli B., Lamhamedi-Cherradi S., Coullin I., Guegan N., Levy J.P., Guillet J.G., Gomard E. Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein. J Virol. 68:1994;7336.
40. Goulder P.J.R., Reid S.W., Price D.A., O'Callaghan C.A., McMichael A.J., Phillips R.E., Jones E.Y. Combined structural and immunological refinement of HIV-1-B8-restricted cytotoxic T lymphocyte epitopes. Eur J Immunol. 27:1997;1515.
41. Klenerman P., Rowland-Jones S., McAdam S., Edwards J., Daenke S., Lalloo D., Köppe B., Rosenberg W., Boyd D., Edwards A., Giangrande P., Phillips R.E., McMichael A.J. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 369:1994;403.